Author: Business Wire

Specsavers Uses Topcon OCT In Its Stores

OAKLAND, N.J.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/specsavers?src=hash” target=”_blank”gt;#specsaverslt;/agt;–Topcon announces that eye health provider Specsavers completed equipping its stores with Topcon’s Optical Coherence Tomography (OCT) instruments.

Global Glaucoma treatment Market Forecast to 2023 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Glaucoma treatment Market Research and Forecast 2018-2023” report has been added to ResearchAndMarkets.com’s offering. The global glaucoma treatment market is emerging with a rapid speed due to some of the major factors such as growing incidences of glaucoma diseases across the globe. Increasing old age population in various regions has become one of the reasons for the growth of this market. Various initiatives by the government and healthcare institutions

Global Tonometers Market Research 2018-2022 – Technological Advances and New Product Launches Gaining Traction – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Tonometers Market 2018-2022” report has been added to ResearchAndMarkets.com’s offering. The tonometers market will register a CAGR of more than 5% by 2022. Introduction of home tonometry to gain traction in the market. Home tonometry improves understanding and management of glaucoma. Also, the growing popularity of self-testing diagnostics is likely to encourage end-users. Market Overview Increasing prevalence of ocular diseases Growing incidences of ocular

Global Phacoemulsification Devices (Consumables & Systems) Market 2019-2023 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Phacoemulsification Devices Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. The phacoemulsification devices market will register a CAGR of close to 4% by 2023. Glaucoma surgery combined with cataract surgery via phacoemulsification to gain traction in the market. Concomitant phacoemulsification and glaucoma surgery are together a viable treatment option for patients with both cataract and glaucoma. The minimally invasive glaucom